Cargando…
Tyrosine kinase inhibitors induced immune thrombocytopenia in chronic myeloid leukemia?
The outcome and quality of life of chronic myeloid leukemia (CML) patients has remarkably changed with the treatment of tyrosine kinase inhibitors (TKIs). Currently, hematopoietic stem cell transplantation (HSCT) is considered mainly as a third line salvage therapy in cases of TKIs resistance or int...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
PAGEPress Publications
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269798/ https://www.ncbi.nlm.nih.gov/pubmed/22593820 http://dx.doi.org/10.4081/hr.2011.e29 |